DERMA SCIENCES INC NEW (DSCI) Misses Q1 GAAP EPS Loss of $0.08
Tweet
Share
E-mailGet Alerts DSCI Hot Sheet
Join SI Premium – FREE
DERMA SCIENCES INC NEW (NASDAQ: DSCI) reported Q1 GAAP EPS of ($0.08), $0.09 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $14.37 million versus the consensus estimate of $15.1 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Movano (MOVE) Misses Q2 EPS by 195c
- Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
